Gout drug shows promise for diabetic kidney protection
NCT ID NCT07177898
First seen Oct 31, 2025 · Last updated May 14, 2026 · Updated 26 times
Summary
This study looked at whether adding allopurinol (a gout medicine) to lisinopril (a blood pressure drug) could better protect kidneys in people with type 2 diabetes who have normal uric acid levels. Eighty participants were split into two groups: one received both drugs, the other lisinopril alone. Researchers tracked kidney function over a year to see if urine albumin levels rose significantly.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for DIABETIC KIDNEY DISEASE (DKD) are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
King Edward Medical University
Lahore, Punjab Province, 54000, Pakistan
Conditions
Explore the condition pages connected to this study.